These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10410241)

  • 1. Synthetic insulin fragment with insulin-like biological activity.
    Prozorovskiy VN; Maksimova EM; Alekseeva AE; Grebenschikova OG; Abakumova OYu ; Kutsenko NG; Ivanov AS; Kniazhev VN; Archakov AI
    Biochem Mol Biol Int; 1999 Jun; 47(6):957-63. PubMed ID: 10410241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A synthetic fragment of insulin with insulin-like biological activity].
    Prozorovskiĭ VN; Maksimova EM; Alekseeva AE; Grebenshchikova OG; Abakumova OIu; Kutsenko NG; Tsvetkova TA; Archakov AI
    Vopr Med Khim; 1996; 42(4):284-91. PubMed ID: 9254511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific interaction of liposomes coated by insulin synthetic fragments with PC 12 cells].
    Maslov DL; Prozorovskiĭ VN
    Vopr Med Khim; 2000; 46(4):377-83. PubMed ID: 11075420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide models of four possible insulin folding intermediates with two disulfides.
    Jia XY; Guo ZY; Wang Y; Xu Y; Duan SS; Feng YM
    Protein Sci; 2003 Nov; 12(11):2412-9. PubMed ID: 14573855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of insulin fragments and study of their physicochemical and immunological properties].
    Panin LE; Tuzikov FV; Poteriaeva ON; Maksiutov AZ; Tuzikova NA; Sabirov AN
    Bioorg Khim; 1997 Dec; 23(12):953-60. PubMed ID: 9499371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical synthesis of the crustacean insulin-like peptide with four disulfide bonds.
    Katayama H; Mukainakano T; Kogure J; Ohira T
    J Pept Sci; 2018 Dec; 24(12):e3132. PubMed ID: 30346100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological properties of an initial degradation product of insulin by insulin-degrading enzyme.
    Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Sakamoto T; Kawase Y; Akiyama H; Taketomi S; Baba S
    Endocrinology; 1989 Jan; 124(1):496-504. PubMed ID: 2642422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes.
    Frick W; Bauer A; Bauer J; Wied S; Müller G
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):163-81. PubMed ID: 9806898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and activity of the B-chain of insulin.
    Ng FM; Zhu SQ; Cui DF; Fan L; Huang YD; Zhang YS
    Biochem Int; 1989 Feb; 18(2):373-81. PubMed ID: 2669756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced specific insulin binding and insulin action with C-terminal B-chain pentapeptide derived from insulin.
    Kikuchi K; Larner J; Freer R; Day AR
    FEBS Lett; 1980 Sep; 119(1):161-4. PubMed ID: 6775976
    [No Abstract]   [Full Text] [Related]  

  • 13. Degradation of insulin by insulin-degrading enzyme and biological characteristics of its fragments.
    Yonezawa K; Yokono K; Yaso S; Hari J; Amano K; Kawase Y; Sakamoto T; Shii K; Imamura Y; Baba S
    Endocrinology; 1986 May; 118(5):1989-96. PubMed ID: 3516656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semisynthetic insulin analogues modified in positions B24, B25 and B29.
    Svoboda I; Brandenburg D; Barth T; Gattner HG; Jirácek J; Velek J; Bláha I; Ubik K; Kasicka V; Pospísek J
    Biol Chem Hoppe Seyler; 1994 Jun; 375(6):373-8. PubMed ID: 7980868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of disulfide bonds in the structure and activity of human insulin.
    Chang SG; Choi KD; Jang SH; Shin HC
    Mol Cells; 2003 Dec; 16(3):323-30. PubMed ID: 14744022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cysteine to serine substitutions in the two inter-chain disulfide bonds of insulin.
    Guo ZY; Feng YM
    Biol Chem; 2001 Mar; 382(3):443-8. PubMed ID: 11347892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationships of des-(B26-B30)-insulin.
    Spoden M; Gattner HG; Zahn H; Brandenburg D
    Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of a fragment of insulin.
    Duckworth WC; Fawcett J; Tsui BT; Bennett RG; Hamel FG
    Biochem Biophys Res Commun; 2004 Jun; 318(4):1019-24. PubMed ID: 15147975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
    Guo ZY; Shen L; Feng YM
    Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical characteristics of an initial degradation product of insulin by insulin-degrading enzyme].
    Yonezawa K
    Nihon Naibunpi Gakkai Zasshi; 1988 Nov; 64(11):1140-56. PubMed ID: 2851464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.